About Matanzas

The mission of the Matanzas LLC is to bring together leadership and proven experience to create a broad range of effective and compliant services to enhance the life-cycle of your product.

Companies who utilize the services of Matanzas benefit by partnering with a global team that understands the value of Global Medical Affairs as part of a broader corporate matrix, shares concerns for budget and time limitations, is a leader of compliance principles and understands the significant impact Medical Affairs can have in positioning a commercial product.

Matanzas consists of Medical Affairs Advisors who bring comprehensive experience and leadership to the pharmaceutical and biotechnology industries. We understand that cross-functional collaboration is the key to success.

With over 100 cumulative years in Medical Affairs, we bring an understanding of the global landscape including every direct, and indirect touch point in medical affairs, from scientific partnerships, investigator sponsored studies, medical information, scientific communications, drug safety, drug distribution, compliance, and regulatory issues, thus providing invaluable customized solutions for scalable global expansion.

Meet Our Team

Sean Turbeville, PhD

Founder, Global Medical Affairs

Sean is currently the President of Matanzas LLC. During his career, he has overseen the development of global medical affairs departments and custom infrastructures to support numerous biopharmaceutical products from pre-launch to post-marketing initiatives. Sean has supported the launch and commercialization of products in North and South America, the European Union, Eastern Europe, Asia Pacific, and the Middle East.

He obtained his PhD in Epidemiology from the University of Oklahoma Health Sciences Center. Sean acts as peer reviewer for several scientific journals and his list of publications includes numerous research and review articles, as well as publications discussing current issues facing medical affair departments including challenges many smaller companies face with the globalization efforts.

Carl S, Hornfeldt, PhD, RPh

Scientific Communications

Carl is currently the president of Apothekon, Inc. In this capacity, he provides medical information and medical writing expertise with an emphasis on specialty diseases to numerous pharmaceutical, biotechnology and medical device companies. He has written or assisted with the publication of over 100 peer-reviewed manuscripts and hundreds of abstracts, standard response letters and other medical information communications for clients in the fields of oncology, dermatology, neurology, ophthalmology and numerous rare diseases such as narcolepsy and liposomal storage disorders. Carl is a graduate of the University of Minnesota College of Pharmacy and College of Veterinary Medicine and the former Director of Medical Information and Drug Safety at Orphan Medical, Inc.

George van Baelen

Global Pharmacovigilance and Medical Information

George spent a significant time of youth in Latin America. He studied Medical and Pharmaceutical Sciences at the Katholieke Universteit Leuven, Belgium and did doctoral work in Toxicology and Advanced Pharmacology at the Joint Graduate Program at Rutgers University / Robert Wood Johnson Medical School in New Jersey, USA, before starting a career in Medical information and Drug Safety in the pharmaceutical industry. He became a Director of Cardiology at United Health, participating in publication planning and authoring several articles on heart disease and its therapies. As Global Director of Pharmacovigilance at AXA, Mr. van Baelen instituted and built comprehensive pharmacovigilance systems while overseeing global Medical Information Services for various biotechnology and pharmaceutical companies.

Mr. van Baelen is currently a Founder and Managing Partner of GB&Partners Consulting LLC, headquartered in Chicago, USA, and travels extensively through out Latin America, advising and assisting US and EU-based clients with the pharmaceutical regulations of Central and South-American countries.

Sharon Leighton, PhD, E.U.

Medical Information and Scientific Communication

Sharon has over 30 years experience in leading research-based pharmaceutical companies in a variety of Medical Communications roles. Includes leadership roles in Medical Information, Pharmacovigilance and Medical Affairs. Working in companies such as AstraZeneca, Merck Sharp & Dohme and Glaxo (now gsk), she managed departmental mergers, restructuring and reorganisations. She has national, European and global medical information experience. Cross cultural and virtual team working are very familiar work environments!

William James Kinnier, PhD

Global Medical Affairs and Medical Information

William, founder of Kinnier Health Care Consulting, assists small companies with the development and use of cloud-based platforms for the creation, approval and delivery of medical information content. Bill has 25 years of previous US and Global Medical Affairs experience across a broad range of therapeutic areas including oncology, immunology, cardiology and neuroscience. Bill received his PhD. in 1977 in Neuroscience and retired from GSK after 25 years.

Colette Diane

Program Manager

Our Experience

Clinical development and commercial support of a broad range of orphan drug products for companies such as:

Neuraltus Pharmaceuticals

Developed by: Code Creative LLC